These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 31526292

  • 1. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
    Wang S, Ai H, Liu L, Zhang X, Gao F, Zheng L, Yi J, Sun L, Yu C, Zhao H, Li Y.
    Am J Physiol Endocrinol Metab; 2019 Nov 01; 317(5):E911-E924. PubMed ID: 31526292
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S, Yang M, Zhao Y, Chen X, Zhang F, Li N, Yao P, Zhu T, Mei H, Wang S, Li Y, Chen S, Le Y.
    Diabetes; 2016 Nov 01; 65(11):3276-3288. PubMed ID: 27495223
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A, Yan H, Liang J, Du C, Zhao X, Sun L, Chen Y.
    Gene; 2017 Sep 05; 627():194-201. PubMed ID: 28627440
    [Abstract] [Full Text] [Related]

  • 4. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F, Ying HM, Wang YY, Cheng BN, Chen J.
    Yonsei Med J; 2020 Sep 05; 61(9):780-788. PubMed ID: 32882762
    [Abstract] [Full Text] [Related]

  • 5. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
    Yan C, Chen J, Li M, Xuan W, Su D, You H, Huang Y, Chen N, Liang X.
    Diabetologia; 2016 Jul 05; 59(7):1524-1532. PubMed ID: 27003684
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H, Wan J, Shan Y, Song X, Jin J, Su Q, Chen S, Lu X, Yang J, Li Q, Song Y, Li B.
    Theranostics; 2021 Jul 05; 11(16):7829-7843. PubMed ID: 34335967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C, Zheng Y, Hu S, Liang X, Li Y, Yu Z, Liu Y, Bian Y, Man Y, Zhao S, Liu X, Liu H, Huang T, Ma J, Chen ZJ, Zhao H, Zhang Y.
    Metabolism; 2024 Mar 05; 152():155766. PubMed ID: 38145825
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice.
    Kabeer SW, Sharma S, Sriramdasu S, Tikoo K.
    Biol Res; 2024 May 14; 57(1):27. PubMed ID: 38745315
    [Abstract] [Full Text] [Related]

  • 10. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W, Zhao Y, Yang Y, Ding Z, Xu X, Weng D, Wang S, Cheng R, Zhang J.
    J Biol Chem; 2021 Jul 14; 297(1):100846. PubMed ID: 34058194
    [Abstract] [Full Text] [Related]

  • 11. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
    Cai H, Jiang Z, Yang X, Lin J, Cai Q, Li X.
    Endocr J; 2020 Apr 28; 67(4):397-408. PubMed ID: 31875589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
    Zhu X, Li H, Wu Y, Zhou J, Yang G, Wang W.
    Int J Mol Med; 2019 Jan 28; 43(1):345-357. PubMed ID: 30431065
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4.
    Li K, Zhang J, Yu J, Liu B, Guo Y, Deng J, Chen S, Wang C, Guo F.
    J Biol Chem; 2015 Mar 27; 290(13):8185-95. PubMed ID: 25657009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
    Yang W, Wang J, Chen Z, Chen J, Meng Y, Chen L, Chang Y, Geng B, Sun L, Dou L, Li J, Guan Y, Cui Q, Yang J.
    Diabetes; 2017 Jul 27; 66(7):1819-1832. PubMed ID: 28411267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.